334 related articles for article (PubMed ID: 1372652)
1. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human erythropoietin in infants with very low birth weights.
Samanci N; Ovali F; Dagoglu
J Int Med Res; 1996; 24(2):190-8. PubMed ID: 8737229
[TBL] [Abstract][Full Text] [Related]
5. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake.
Bechensteen AG; Hågå P; Halvorsen S; Liestøl K; Lindemann R; Whitelaw A; Tølløfsrud PA; Daae L; Thorstensen K; Sundal E
Eur J Pediatr; 1997 Jan; 156(1):56-61. PubMed ID: 9007493
[TBL] [Abstract][Full Text] [Related]
6. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.
Ohls RK; Ehrenkranz RA; Wright LL; Lemons JA; Korones SB; Stoll BJ; Stark AR; Shankaran S; Donovan EF; Close NC; Das A
Pediatrics; 2001 Oct; 108(4):934-42. PubMed ID: 11581447
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human erythropoietin on transfusion needs in preterm infants.
Yeo CL; Choo S; Ho LY
J Paediatr Child Health; 2001 Aug; 37(4):352-8. PubMed ID: 11532054
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in anemia of prematurity.
Whitehall JS; Patole SK; Campbell P
Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
10. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants.
Carnielli VP; Da Riol R; Montini G
Arch Dis Child Fetal Neonatal Ed; 1998 Jul; 79(1):F44-8. PubMed ID: 9797624
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
[TBL] [Abstract][Full Text] [Related]
12. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
[TBL] [Abstract][Full Text] [Related]
14. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
Meyer MP; Haworth C; Meyer JH; Commerford A
J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
[TBL] [Abstract][Full Text] [Related]
16. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy.
Nazir S; Peverini RL; Deming DD; Hopper AO; Vyhmeister NR
Arch Pediatr Adolesc Med; 2002 Jun; 156(6):540-4. PubMed ID: 12038884
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions.
Al-Kharfy T; Smyth JA; Wadsworth L; Krystal G; Fitzgerald C; Davis J; Milner R
J Pediatr; 1996 Jul; 129(1):89-96. PubMed ID: 8757567
[TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R
J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819
[TBL] [Abstract][Full Text] [Related]
20. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
Ohls RK; Christensen RD
J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
